Back to top

Lunai Bioworks advances biomarker discovery preclinical program in Parkinson’s

Lunai Bioworks (RENB) announced advancement of its biomarker discovery preclinical program in Parkinson’s Disease. The initiative leverages BioSyme...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE: